Singh, Rana P <br/><br/>
Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.  [electronic resource] 

 -  Carcinogenesis  Dec 2007 
 - 2567-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1460-2180 
<br/><br/><label>Standard No.: </label>10.1093/carcin/bgm218  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anticarcinogenic Agents--administration & dosage<br/>Cell Proliferation--drug effects<br/>Cyclin-Dependent Kinase Inhibitor p21--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p27--metabolism<br/>Diet<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Inhibitor of Apoptosis Proteins<br/>Insulin-Like Growth Factor Binding Protein 3--metabolism<br/>Male<br/>Mice<br/>Mice, Nude<br/>Microtubule-Associated Proteins--metabolism<br/>Neoplasm Proteins--metabolism<br/>Neoplasm Transplantation<br/>Prostatic Neoplasms--metabolism<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Silybin<br/>Silymarin--administration & dosage<br/>Survivin<br/>Transplantation, Heterologous<br/>Vascular Endothelial Growth Factor A--metabolism